News By/Courtesy: Aashi Nema | 26 Dec 2018 8:31am IST

Pocket Colposcope, developed by Dr. Nimmi Ramanujam’s team at Duke University, for cervical cancer screening has been successfully tried by All India Institute of Medical Sciences (AIIMS). According to a gynecologist in AIIMS Neerja Bhatla, the device is very small and easy to use, store and transport. Health workers can easily learn its usages and record the images to transmit them to experts elsewhere. The colposcope looks like an additional prolonged tampon with a high-end camera and a light that can look at the cervix with as much or even more clarity than the current device. It can demeanor through a cervix with improved clarity than a customary colposcope. 

The idea of creating a device that would relieve women from hardships that they go through during the cervical screening came from a book by James Marion Sims, a father of complicated gynecology. The Pocket Colposcope is very useful because of its two vital characteristics. Firstly, it costs just $500 against the currently used machine which costs $15,000 and secondly, it is not painful or unpleasant like the benefaction test. 

Dr. Ramanujam is already in talks with the Tamil Nadu Government to introduce it to some primary care centers in the state. The cervical cancer is one of the leading cancers among women after breast cancer. Women aged 15 years and older are at risk of developing cervical cancer. Statistical reports of National Health Portal states that every year 1,22,844 women are diagnosed with cervical cancer and 67,477 die from the disease in India. It is the second most common cancer among women of the age 15 to 44 years.

Section Editor: Shreyashi Tiwari | 26 Dec 2018 8:31am IST

Tags : #Cervical #Cancer #Pocket #Colposcope #Tried #AIIMS #Successful

Health & Food Related Latest News

Copyright Kalyan Krishna MediaZ Private Limited. All rights reserved. Unless otherwise indicated, all materials on these pages are copyrighted by Kalyan Krishna MediaZ Private Limited. All rights reserved. No part of these pages, either text or image may be used for any purpose. By continuing past this page, you agree to our Terms of Service, Cookie Policy, Privacy Policy and Content Policies.